Skip to main content

External Beam Radiotherapy for Bone Metastases

CBE ID
1822
1.4 Project
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
1.3 Measure Description

This measure reports the percentage of patients, regardless of age, with a diagnosis of painful bone metastases and no history of previous radiation who receive external beam radiation therapy (EBRT) with an acceptable fractionation scheme as defined by the guideline.

        • 1.14 Numerator

          All patients, regardless of age, with painful bone metastases, and no previous radiation to the same anatomic site who receive EBRT with any of the following recommended fractionation schemes: 30Gy/10fxns, 24Gy/6fxns, 20Gy/5fxns, 8Gy/1fxn.

        • 1.15 Denominator

          All patients with painful bone metastases and no previous radiation to the same anatomic site who receive EBRT

        • Exclusions

          The medical reasons for denominator exclusions are:
          1) Previous radiation treatment to the same anatomic site;
          2) Patients with femoral axis cortical involvement greater than 3 cm in length;
          3) Patients who have undergone a surgical stabilization procedure; and
          4) Patients with spinal cord compression, cauda equina compression or radicular pain

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed Cancer Fall Cycle 2017
          Initial Endorsement
          Last Updated
          Removal Date
        • Steward
          American Society for Radiation Oncology
          Steward Organization POC Email